Today: 14 June 2026
Browse Category

TSXV:SCA 25 May 2026

Scandium Canada Jumps 17% With Critical-Minerals Traders Watching Quebec Stock

Scandium Canada Jumps 17% With Critical-Minerals Traders Watching Quebec Stock

Scandium Canada Ltd. shares rose 16.7% to C$0.175 on thin TSX Venture trading Monday, as Canadian markets stayed open during the U.S. Memorial Day holiday. The company’s next steps include alloy qualification, a Crater Lake pre-feasibility study, and new drilling. Its latest release detailed a partnership with Turkey’s ALPOMET on scandium-based alloys. Scandium Canada reported C$15 million in cash and C$6.9 million in government funding in April.
25 May 2026
·

Stock Market Today

  • Indivior's Chief Scientific Officer Sells Shares Amid Stock Rally: Investor Implications
    June 14, 2026, 12:02 AM EDT. Christian Heidbreder, Chief Scientific Officer at Indivior Pharmaceuticals, sold 18,586 shares valued at $707,383 on June 11, 2026, representing 7.54% of his holdings. Post-sale, he retains 227,923 shares worth about $8.69 million, maintaining a 0.18% stake. The sale occurred during a significant stock price surge, with Indivior shares rising 177% over the past year, reflecting strong market performance amid growth in opioid dependence therapies. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, not signaling insider concerns. Indivior's strategy focuses on buprenorphine-based addiction treatments, with $1.29 billion in trailing twelve-month revenue and $252 million net income, underscoring its established market position and ongoing research-led expansion.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Go toTop